Plains GP (NYSE:PAGP - Get Free Report) had its price objective hoisted by equities researchers at Truist Financial from $23.00 to $25.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a "buy" rating on the pipeline company's stock. Truist Financial's target price would suggest a potential downside of 1.22% from the company's previous close.
PAGP has been the subject of several other research reports. Wells Fargo & Company increased their price objective on shares of Plains GP from $22.00 to $23.00 and gave the company an "equal weight" rating in a research report on Tuesday, May 12th. Citigroup upped their target price on shares of Plains GP from $20.00 to $23.00 and gave the company a "neutral" rating in a research note on Thursday, May 14th. The Goldman Sachs Group raised shares of Plains GP from a "sell" rating to a "neutral" rating and raised their price target for the company from $18.00 to $24.00 in a report on Wednesday, June 3rd. Barclays lifted their price target on shares of Plains GP from $18.00 to $21.00 and gave the stock an "underweight" rating in a research note on Friday, April 10th. Finally, US Capital Advisors lowered shares of Plains GP from a "strong-buy" rating to a "moderate buy" rating in a report on Friday, May 29th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $23.18.
Check Out Our Latest Stock Report on PAGP
Plains GP Price Performance
PAGP stock opened at $25.31 on Wednesday. The firm has a market cap of $5.01 billion, a P/E ratio of 47.76 and a beta of 0.45. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.92 and a current ratio of 1.01. Plains GP has a 1 year low of $16.68 and a 1 year high of $26.15. The stock has a 50-day simple moving average of $24.37 and a 200-day simple moving average of $22.87.
Hedge Funds Weigh In On Plains GP
A number of hedge funds have recently added to or reduced their stakes in the business. CWM LLC increased its stake in Plains GP by 8.5% during the fourth quarter. CWM LLC now owns 8,113 shares of the pipeline company's stock valued at $155,000 after acquiring an additional 636 shares during the period. Diesslin Group Inc. raised its position in Plains GP by 0.8% in the 2nd quarter. Diesslin Group Inc. now owns 82,841 shares of the pipeline company's stock valued at $2,011,000 after purchasing an additional 664 shares during the last quarter. McIlrath & Eck LLC lifted its position in Plains GP by 5.9% during the 1st quarter. McIlrath & Eck LLC now owns 12,133 shares of the pipeline company's stock worth $295,000 after buying an additional 677 shares in the last quarter. Quantinno Capital Management LP lifted its position in shares of Plains GP by 1.8% during the first quarter. Quantinno Capital Management LP now owns 40,208 shares of the pipeline company's stock worth $976,000 after purchasing an additional 698 shares in the last quarter. Finally, IVC Wealth Advisors LLC lifted its holdings in Plains GP by 4.7% during the 1st quarter. IVC Wealth Advisors LLC now owns 16,105 shares of the pipeline company's stock worth $391,000 after buying an additional 722 shares in the last quarter. Institutional investors and hedge funds own 88.30% of the company's stock.
About Plains GP
(
Get Free Report)
Plains GP Holdings, L.P. NYSE: PAGP serves as the general partner of Plains All American Pipeline, L.P., one of North America's leading energy infrastructure companies. Through its ownership of a 2% general partner interest and incentive distribution rights (IDRs), Plains GP Holdings participates in the governance and cash distribution structure of a diversified portfolio of crude oil and natural gas liquids gathering, transportation, storage, and terminaling assets.
The company's primary business activities include overseeing the strategic direction and capital allocation decisions for its affiliated midstream operations.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Plains GP, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plains GP wasn't on the list.
While Plains GP currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.